FormFactor
FORM
139.80
-1.50
-1.06%
FormFactor
US · FORM
#1346 by market cap
Listed 1970
139.80
-1.50
-1.06%
Live - 5344 symbols - heartbeat 311s ago
· 2026-10-08 07:00
Pre-market
137.26
-1.82%
After-hours
139.98
+0.13%
Overnight
138.40
-1.00%
- Market cap
- 10.92B
- P/E (TTM)i
- 96.41
- P/Bi
- 9.83
- EPSi
- 0.69
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on FORM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 36.11, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.80% YoY
Margins
- Gross margin
- 39.34%
- Operating margin
- 7.66%
- Net margin
- 6.93%
Key ratios & quality
- Enterprise valuei
- 10.67B
- PEG ratioi
- 41.46
- Altman Z-Scorei
- 36.11
PEG uses trailing P/E against the 3-year net income growth rate (2.33%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 529.68M | 589.46M | 693.62M | 769.67M | 747.94M | 663.10M | 763.60M | 784.99M |
| Gross profit | 210.34M | 237.50M | 287.92M | 322.77M | 296.01M | 258.58M | 307.92M | 308.85M |
| Selling & admin expenses | 99.25M | 106.34M | 115.10M | 123.79M | 131.88M | 133.01M | 141.79M | 133.07M |
| Research & development | 74.98M | 81.50M | 89.03M | 100.94M | 109.22M | 115.77M | 121.94M | 115.68M |
| Operating profit | 36.11M | 49.66M | 83.79M | 98.04M | 54.91M | 9.80M | 44.20M | 60.10M |
| Pretax profit | 33.93M | 51.06M | 85.18M | 98.50M | 57.87M | 89.27M | 79.41M | 69.39M |
| Tax | -70.11M | 11.72M | 6.65M | 14.58M | 7.13M | 6.88M | 9.80M | 13.00M |
| Net profit | 104.04M | 39.35M | 78.52M | 83.92M | 50.74M | 82.39M | 69.61M | 54.36M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 1.38 | 0.51 | 0.99 | 1.06 | 0.65 | 1.05 | 0.89 | 0.69 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 171.36M | 195.80M | 202.68M | 215.16M | 226.14M | 258.24M |
| Gross profit | 64.52M | 72.94M | 80.63M | 90.76M | 86.79M | 130.92M |
| Selling & admin expenses | 33.45M | 31.48M | 32.97M | 35.17M | 32.29M | 37.17M |
| Research & development | 27.80M | 28.79M | 28.69M | 30.40M | 30.78M | 31.10M |
| Operating profit | 3.27M | 12.66M | 18.97M | 25.19M | 23.72M | 62.66M |
| Pretax profit | 7.48M | 14.94M | 20.43M | 26.55M | 19.26M | 60.69M |
| Tax | 1.08M | 2.37M | 5.94M | 3.62M | 396.00K | 6.73M |
| Net profit | 6.40M | 9.09M | 15.66M | 23.22M | 20.38M | 56.21M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.08 | 0.12 | 0.20 | 0.29 | 0.26 | 0.71 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 337.82M | 419.04M | 487.07M | 524.04M | 474.55M | 573.78M | 605.13M | 557.05M |
| Cash & ST investments | 149.00M | 220.87M | 255.04M | 276.07M | 238.14M | 328.32M | 360.02M | 275.17M |
| Inventory | 77.71M | 83.26M | 99.23M | 111.55M | 123.16M | 111.69M | 101.68M | 110.88M |
| Total assets | 728.22M | 839.88M | 963.22M | 1.02B | 1.01B | 1.11B | 1.15B | 1.22B |
| Total current liabilities | 102.52M | 136.56M | 154.57M | 148.75M | 149.67M | 131.10M | 131.35M | 123.86M |
| Short-term debt | 29.84M | 49.40M | 16.22M | 16.83M | 8.40M | 9.50M | 9.47M | 8.80M |
| Long-term debt | 34.97M | 15.64M | 24.98M | 15.43M | 14.39M | 13.31M | 12.21M | 11.07M |
| Total liabilities | 148,058,000.00 | 198,885,000.00 | 219,133,000.00 | 204,740,000.00 | 199,943,000.00 | 197,990,000.00 | 198,447,000.00 | 188,959,000.00 |
| Total equity | 580.16M | 641.00M | 744.08M | 815.78M | 808.29M | 908.80M | 947.77M | 1.04B |
| Retained earnings | -283.59M | -244.24M | -165.72M | -81.79M | -31.06M | 51.33M | 120.95M | 175.31M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 551.24M | 525.26M | 559.26M | 557.05M | 600.81M | 669.51M |
| Cash & ST investments | 298.99M | 249.33M | 266.03M | 275.17M | 303.28M | 345.64M |
| Inventory | 109.97M | 110.79M | 108.83M | 110.88M | 112.88M | 121.41M |
| Total assets | 1.16B | 1.18B | 1.20B | 1.22B | 1.26B | 1.34B |
| Total current liabilities | 124.02M | 123.97M | 130.12M | 123.86M | 132.11M | 164.17M |
| Short-term debt | 9.57M | 9.04M | 8.53M | 8.80M | 9.47M | 9.47M |
| Long-term debt | 11.93M | 11.64M | 11.36M | 11.07M | 10.78M | 10.49M |
| Total liabilities | 190,293,000.00 | 191,585,000.00 | 193,377,000.00 | 188,959,000.00 | 197,051,000.00 | 231,120,000.00 |
| Total equity | 965.87M | 990.02M | 1.01B | 1.04B | 1.06B | 1.11B |
| Retained earnings | 127.35M | 136.43M | 152.09M | 175.31M | 195.69M | 251.90M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 68.70M | 121.05M | 169.26M | 139.36M | 131.79M | 64.60M | 117.53M | 115.40M |
| Depreciation & amortization | 43.69M | 44.86M | 48.69M | 44.52M | 38.04M | 37.45M | 32.90M | 37.59M |
| Free cash flow | 48.83M | 100.20M | 113.39M | 72.87M | 66.53M | 8.58M | 79.10M | 11.74M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 7.71M | 8.09M | 10.01M | 10.65M | 10.50M | 8.82M | 9.75M | 26.12M |
| Ending cash balance | 100.55M | 147.94M | 191.10M | 155.34M | 112.98M | 181.27M | 197.21M | 107.05M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 23.54M | 18.89M | 26.99M | 45.98M | 44.96M | 61.80M |
| Depreciation & amortization | 8.83M | 9.56M | 9.77M | 9.43M | 9.17M | 8.97M |
| Free cash flow | 4.96M | -47.36M | 19.49M | 34.66M | 29.77M | 52.20M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 21.58M | -24.59M | 2.89M | 26.24M | 5.84M | 0 |
| Ending cash balance | 133.30M | 70.91M | 101.11M | 107.05M | 126.45M | 113.15M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.03 | 6.44 | 11.34 | 10.76 | 6.25 | 9.60 | 7.50 | 5.48 |
| ROA %i | 15.13 | 5.02 | 8.71 | 8.46 | 5.00 | 7.79 | 6.18 | 4.59 |
| ROIC %i | 17.44 | 5.61 | 10.07 | 9.92 | 5.67 | 8.38 | 5.93 | 4.49 |
| 5-year avg ROE %i | 4.11 | 6.72 | 9.09 | 11.62 | 10.96 | 8.88 | 9.09 | 7.92 |
| EBIT margin %i | 7.03 | 8.99 | 12.40 | 12.88 | 7.81 | 13.53 | 10.45 | 8.91 |
| FCF / sales %i | 9.22 | 17.00 | 16.35 | 9.47 | 8.90 | 1.29 | 10.36 | 1.50 |
| Current ratioi | 3.30 | 3.07 | 3.15 | 3.52 | 3.17 | 4.38 | 4.61 | 4.50 |
| Quick ratioi | 2.38 | 2.33 | 2.35 | 2.63 | 2.18 | 3.29 | 3.54 | 3.23 |
| Debt / assetsi | 8.90 | 11.21 | 7.18 | 6.20 | 5.00 | 4.35 | 3.42 | 2.64 |
| LT debt / equityi | 6.03 | 6.98 | 7.12 | 5.69 | 5.19 | 4.25 | 3.14 | 2.28 |
| Interest coveragei | 11.24 | 27.66 | 99.58 | 164.62 | 100.95 | 213.04 | 190.98 | 134.19 |
| Revenue CAGR (3Y) %i | 23.33 | 15.37 | 8.14 | 13.27 | 8.26 | -1.49 | -0.26 | 1.62 |
| Net income CAGR (3Y) %i | -- | -- | 24.27 | -6.91 | 8.85 | 1.61 | -6.04 | 2.33 |
| FCF CAGR (3Y) %i | 21.12 | 157.01 | 18.26 | 14.27 | -12.76 | -57.71 | 2.77 | -43.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.74 | 4.53 | 4.16 | 5.48 | 6.75 | 10.99 |
| ROA %i | 4.77 | 3.76 | 3.47 | 4.59 | 5.67 | 9.15 |
| ROIC %i | 4.23 | 3.21 | 3.09 | 4.49 | 5.76 | 9.89 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.71 | 10.06 | 10.32 | 8.91 | 10.76 | 15.56 |
| FCF / sales %i | 8.41 | 0.48 | 0.70 | 1.50 | 4.35 | 15.09 |
| Current ratioi | 4.44 | 4.24 | 4.30 | 4.50 | 4.55 | 4.08 |
| Quick ratioi | 3.21 | 2.94 | 3.07 | 3.23 | 3.30 | 3.05 |
| Debt / assetsi | 3.24 | 3.04 | 2.76 | 2.64 | 2.54 | 2.23 |
| LT debt / equityi | 2.89 | 2.71 | 2.44 | 2.28 | 2.12 | 1.84 |
| Interest coveragei | -- | -- | -- | 134.19 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Probe Cards is the largest reported line at 81.20% of revenue, across 2 reported segments.
- The next-largest line, Systems, is a distant second at 18.80% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Probe Cards81.20%
Systems18.80%
Quote time 2026-10-08 07:00:03 · For reference only, not investment advice and not tailored to your situation.